Screener
OrthoPediatrics KIDS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Product | ||||||
| Scoliosis | $16.88M-8.9% | $15.44M+13.0% | $17.6M+12.6% | $16.26M+4.0% | $18.52M+35.4% | |
| Sports medicine/other | $1M+10.5% | $875K-0.6% | $1.37M+119% | $846K-34.7% | $905K-32.9% | |
| Trauma and deformity | $52.63M+26.4% | $43.05M+13.7% | $42.64M+17.1% | $44.14M+17.3% | $41.66M+10.3% | |
| Net revenue by Geography | ||||||
| International | $15.72M+21.5% | $14.05M+22.0% | $12.96M+32.6% | $12.53M+5.7% | $12.94M+12.0% | |
| U.S. | $54.79M+13.8% | $45.31M+10.8% | $48.65M+13.4% | $48.72M+14.1% | $48.15M+16.7% |
FAQ
- How does OrthoPediatrics break its business down?
- OrthoPediatrics (KIDS) reports net revenue by product across 3 parts — Scoliosis, Sports medicine/other and Trauma and deformity. Each is extracted from the segment footnotes and tracked over time.
- Where does OrthoPediatrics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in OrthoPediatrics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
